Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1
Recruiting2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT07223385Phase 2Recruiting
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
CV RiskProstate Cancer (Diagnosis)Prostate Cancer Stage IV
PrincipalinvestigatorStart date: 2026-07-15
NCT06373497Early Phase 1Recruiting
Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography
Oligometastatic Disease
PrincipalinvestigatorStart date: 2025-06-19
NCT05403736Not ApplicableCompleted
Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial
Cancer
PrincipalinvestigatorStart date: 2022-10-07

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT07223385Phase 2PrincipalInvestigator

High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)

CV RiskProstate Cancer (Diagnosis)Prostate Cancer Stage IV
Recruiting
NCT06373497Early Phase 1PrincipalInvestigator

Real-Time Atherosclerosis Activity After Thoracic Radiotherapy Using Sodium Fluoride Positron Emission Tomography

Oligometastatic Disease
Recruiting
NCT05403736Not ApplicablePrincipalInvestigator

Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial

Cancer
Completed

All 3 trials loaded